- Home
- BANX vs RPID Comparison
BANX vs RPID Comparison
Compare BANX & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANX
- RPID
- Stock Information
- Founded
- BANX 2013
- RPID 2006
- Country
- BANX United States
- RPID United States
- Employees
- BANX N/A
- RPID N/A
- Industry
- BANX Trusts Except Educational Religious and Charitable
- RPID Medical Specialities
- Sector
- BANX Finance
- RPID Health Care
- Exchange
- BANX Nasdaq
- RPID Nasdaq
- Market Cap
- BANX 149.8M
- RPID 154.7M
- IPO Year
- BANX N/A
- RPID 2021
- Fundamental
- Price
- BANX $21.42
- RPID $4.13
- Analyst Decision
- BANX
- RPID Strong Buy
- Analyst Count
- BANX 0
- RPID 2
- Target Price
- BANX N/A
- RPID $8.00
- AVG Volume (30 Days)
- BANX 23.4K
- RPID 124.8K
- Earning Date
- BANX 06-17-2025
- RPID 11-07-2025
- Dividend Yield
- BANX 9.66%
- RPID N/A
- EPS Growth
- BANX N/A
- RPID N/A
- EPS
- BANX 2.35
- RPID N/A
- Revenue
- BANX $29,467,794.00
- RPID $30,523,000.00
- Revenue This Year
- BANX N/A
- RPID $16.63
- Revenue Next Year
- BANX N/A
- RPID $21.98
- P/E Ratio
- BANX $8.88
- RPID N/A
- Revenue Growth
- BANX 2.73
- RPID 16.63
- 52 Week Low
- BANX $17.99
- RPID $0.87
- 52 Week High
- BANX $21.67
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- BANX 57.96
- RPID 62.21
- Support Level
- BANX $21.03
- RPID $3.93
- Resistance Level
- BANX $21.75
- RPID $4.29
- Average True Range (ATR)
- BANX 0.34
- RPID 0.35
- MACD
- BANX 0.06
- RPID 0.03
- Stochastic Oscillator
- BANX 96.52
- RPID 80.85
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.